Plan to Ditch the Mask After Vaccination? Not So Fast.

With 50 million Americans vaccinated against coronovirus, and millions joining the ranks every day, the immediate question on many minds is: When can I throw off my mask?

This is a deeper question, it seems – about a return to normalcy, how soon-to-be-vaccinated Americans can embrace loved ones, meet up with friends, and play music, shopping malls, and without feeling threatened by coronoviruses Can go to the restaurant.

Certainly many state officials are ready. On Tuesday, Texas lifted its facade mandate, with all restrictions on businesses, and Mississippi quickly followed suit. The governors in both states noted a decline in infection rates and an increasing number of citizens.

But the epidemic is not over yet and scientists are advising patience.

It seems clear that small groups of vaccinated people can get together without worrying too much about infecting each other. The Centers for Disease Control and Prevention hopes to soon issue new guidelines that will touch on small gatherings of vaccinated Americans.

But when vaccinated people can apply masks in public places, it will depend on how quickly the disease rate falls and what percentage of people in the surrounding community remain unwell.

Why? Scientists do not know if the vaccinators spread the virus to those who are uneducated. Although all Kovid-19 vaccines are fantastic at protecting people from serious illness and death, research is not clear on how they prevent the virus from taking root in an immunized person’s nose and then spreading to others.

It is not an uncommon disease for the vaccine, but not an infection. Infections against the flu, rotavirus, polio, and pertussis are all incomplete in this way.

Vaccine “medical vaccines” in Montana are under much more scrutiny than many previous vaccines.

And now coronavirus viruses that baffle the immune system are replacing stones. Some vaccines are less effective at preventing infection with certain variants, and in principle may allow more viruses to spread.

Research yet available to prevent the transmission of vaccines is preliminary but promising. “We believe there is a shortage,” said Natalie Dean, a biostatistician at the University of Florida. “We don’t know the exact magnitude, but it’s not 100 percent.”

Still, an 80 percent drop in immunity may also be enough for immunized people to bounce off their masks, experts said – especially once the majority of the population is vaccinated, and the rate of cases, hospitals and deaths In form of.

But most Americans are still unpublished, and more than 1,500 people are dying every day. Therefore, given the uncertainty surrounding transmission, even those who are vaccinated should continue to protect others by wearing masks, experts said.

Director of the National Institute for Allergy and Infectious Diseases, Drs. Anthony S. Fauci said, “We should wear masks until we actually prove that vaccines prevent transmission.”

That evidence is not yet at hand because clinical trials for vaccines were designed to test whether vaccines prevent severe disease and death, which usually reflects the virus’s effect on the lungs. On the other hand, transmission is driven by its growth in the nose and throat.

Inspired by the vaccine, the body’s immune fighters should curb the virus immediately after infection, reducing the duration of infection and reducing the volume in the nose and throat. This should reduce the likelihood that a vaccinated person may infect others.

Animal studies support the theory. In one study, when monkeys were vaccinated and then exposed to the virus, seven out of eight animals had no detectable virus in their nose or lung fluids, noted Juliet Morrison, University of California, Riverside Was a virologist.

Similarly, data from a few dozen participants in the Modern Trial were tested when they received their second dose, stating that the first dose had reduced infection rates by about two-thirds.

Another small batch of data recently emerged from the Johnson & Johnson test. Researchers looked for signs of infection in 3,000 participants up to 71 days after the single-dose vaccination. The risk of infection was about 74 percent lower in that study.

“I think it’s very powerful,” said Dan Barch, a virologist at Beth Israel Medical Center in Boston, who led one of the testing sites. “Those number estimates may change with more data, but the effect seems quite strong.”

More data from Pfizer-BioNTech and Moderna is expected in the coming months.

But clinical trials can reduce the potency of a vaccine, as those who already participate try to be cautious and are advised on precautions during the test.

Instead some researchers are tracking the transition between immunized people in real-world settings. For example, a Study in scotland Tested every two weeks, regardless of symptoms, on health care workers who received the Pfizer-BioNotech vaccine. Investigators found that the vaccine’s effectiveness in preventing infection was 70 percent after one dose and 85 percent after another.

Researchers in Israel Transition rated Immunized around 600,000 people and tried to locate their domestic contacts. Scientists saw a 46 percent drop in infection after the first dose and 92 percent after the second. (In-study infections can occur in people without symptoms.)

But to properly evaluate transmission, researchers really need to know which immunized people become infected, and then detect the spread of the virus among their contacts with genetic analysis.

“This is really the ideal way to do this,” Dr. Said Larry Corey, a specialist in vaccine development at the Fred Hutchinson Cancer Research Center in Seattle. He is hoping to conduct such a study in college-age students.

But until the results of such studies are available, what precautions should people take from vaccination? At the moment, many experts believe that what is permissible will depend to a large extent on the number of cases in the surrounding community.

The higher the number of cases, the greater the probability of spread – and the more effective vaccines to prevent the spread.

“If the case number is zero, it doesn’t matter whether it’s 70 percent or 100 percent,” said health policy expert Zoe McLaren of the University of Maryland, referring to vaccine effectiveness.

Policies wearing masks will also depend on how many unqualified people remain in the population. Americans may need to be vigilant until vaccination rates are low. But people will be able to relax a little as those rates increase, and begin to return to normalcy as soon as they step out of others to infect the virus.

“A lot of people have in mind that the mask is the first thing you give up,” Dr. McLaren said. In fact, she said, masks provide more freedom by allowing people to go to concerts, travel on buses or airplanes, or shop with unqualified people around.

Ultimately, masks are a form of civil responsibility, said Saba Klein, an immunologist at the Johns Hopkins Bloomberg School of Public Health.

“Have you worn a mask to protect yourself from serious Kovid, or are you wearing a mask for public health?” Dr. Klein said. “It is right to do your part in the community beyond yourself.”

Source link

Leave a Comment